A Phase Ia/Ib Clinical Study of GH56 Capsules in Subjects With MTAP-Deleted Advanced Solid Tumors

NCT06796699 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors With MTAP Gene Deletion

Interventions

DRUG: GH56 Capsule

Sponsor

Suzhou Genhouse Bio Co., Ltd.